AriBio Companies
AriBio is a leading pharmaceutical company that focuses on developing innovative and life-saving drugs. With a strong commitment to research and development, AriBio aims to address unmet medical needs and improve patient outcomes. Their portfolio includes a wide range of therapeutic areas, including oncology, neurology, and cardiovascular diseases. AriBio has achieved significant milestones in drug discovery and has successfully brought several breakthrough medications to market, making a positive impact on the lives of millions of patients worldwide.
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Seongnam, Kyonggi-do, South Korea
Founded Date:
2010
Employees Number:
80
Register and Claim Ownership